<> Beta Drugs Share Price Today: Live Beta Drugs Share Price NSE/BSE | 5paisa
BETA

Beta Drugs Share PriceBeta Drugs

₹634.5
9.5 (1.52%)
As on 05 February, 2023 | 20:35 BSE: 531481 NSE: BETA

Beta Drugs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Beta Drugs

Start SIP

Beta Drugs Share Price

  • Over 1 Month -7.37%
  • Over 3 Month -12.3%
  • Over 6 Month -19.38%
  • Over 1 Year 4.36%

Beta Drugs Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr 610
Price to Book Ratio 6.6
EPS 14.8
Dividend 0
Relative Strength Index 40.47
Money Flow Index 51.34
MACD Signal -13.5
Average True Range 26.73

Beta Drugs Investment Rating

  • Master Rating:
  • Beta Drugs has an operating revenue of Rs. 456.69 Cr. on a trailing 12-month basis. An annual revenue growth of 58% is outstanding, Pre-tax margin of 19% is great, ROE of 26% is exceptional. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 88 which is a GOOD score indicating consistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Beta Drugs Financials
Indicator
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr

Beta Drugs Technicals

EMA & SMA

Current Price
₹634.5
9.5 (1.52%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • 653.99
  • 50 Day
  • 679.04
  • 100 Day
  • 701.72
  • 200 Day
  • 693.55
  • 20 Day
  • 658.34
  • 50 Day
  • 682.69
  • 100 Day
  • 716.47
  • 200 Day
  • 750.34

Beta Drugs Resistance and Support

PIVOT
₹631.99
Resistance
First Resistance 641.97
Second Resistance 658.94
Third Resistance 668.92
RSI 40.47
MFI 51.34
MACD Single Line -13.5
MACD -15.87
Support
First Resistance 615.02
Second Resistance 605.04
Third Resistance 588.07

Beta Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,400 160,008 66.67
Week 3,800 300,010 78.95
1 Month 2,505 204,764 81.75
6 Month 3,288 271,523 82.58

Beta Drugs Result Highlights

Beta Drugs Synopsis

NSE-Medical-Diversified

Beta Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 124.85 Cr. and Equity Capital is Rs. 9.61 Cr. for the Year ended 31/03/2022. Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969.
Market Cap 610
Sales 125
Shares in Float 0.32
No of funds 2
Yield
Book Value 7.88
U/D Vol ratio 0.7
LTDebt / Equity 7
Alpha 0.08
Beta 0.56

Beta Drugs

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 66.71%66.71%66.71%
Foreign Portfolio Investors 0.29%0.29%0.29%
Individual Investors 22.6%22.61%
Others 10.4%10.39%33%

Beta Drugs Management

Name Designation
Mr. Rahul Batra Chairman & Managing Director
Mr. Varun Batra Joint Managing Director
Mr. Balwant Singh Whole Time Director
Mrs. Seema Chopra Whole Time Director
Mr. Ashutosh Shukla Whole Time Director
Mr. Manmohan Khanna Independent Director
Mr. Rohit Parti Independent Director

Beta Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Beta Drugs Corporate Action

Date Purpose Remarks
2022-10-27 Quarterly Results
2022-04-27 Audited Results
2021-10-25 Quarterly Results
2021-04-27 Audited Results
2020-10-19 Quarterly Results

Beta Drugs FAQs

What is Share Price of Beta Drugs ?

Beta Drugs share price is ₹634 As on 05 February, 2023 | 20:21

What is the Market Cap of Beta Drugs ?

The Market Cap of Beta Drugs is ₹610 Cr As on 05 February, 2023 | 20:21

What is the P/E ratio of Beta Drugs ?

The P/E ratio of Beta Drugs is As on 05 February, 2023 | 20:21

What is the PB ratio of Beta Drugs ?

The PB ratio of Beta Drugs is 6.6 As on 05 February, 2023 | 20:21

Q2FY23